US Patent 11357821 Recombinant clostridial neurotoxins with increased duration of effect
Patent 11357821 was granted and assigned to Merz Pharma on June, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 9, 2019
Date of Patent
June 14, 2022
Patent Applicant
Patent Application Number
16707827
Patent Citations
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11357821 Recombinant clostridial neurotoxins with increased duration of effect
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
